Pacira Legal Information

Pacira BioSciences, Inc. has prepared this information in good faith based on current information reasonably available. No liability whatsoever is accepted and no representation, warranty or undertaking, express or implied, is or will be made by Pacira or any of Pacira’s affiliates, or any of their respective agents, directors, officers, employees, advisers, or representatives (“Agents”), for any information, projections, or any of the opinions contained herein, or for any errors, omissions or misstatements. Neither Pacira nor any of Pacira’s affiliates, nor any of their respective Agents makes or has authorized to be made any representations or warranties (express or implied) in relation to Pacira or this website or as to the truth, accuracy or completeness of the information contained on this website, or any other written or oral statement provided in connection herewith, (the “Data”). Neither the issue of the Data nor any part of its contents constitutes an offer to sell or invitation to purchase any of the products or services or assets described herein or any of the same relating thereto (the “Products”), and no information set out in the Data or referred to in any other written or oral information provided in connection with the Products is intended to form the basis of any decision to enter into any agreement or transaction with respect to the Products. Neither the issue of the Data nor any part of its contents is to be taken as any form of commitment on the part of Pacira or any of Pacira’s affiliates, nor any of their respective Agents to proceed with any agreement or transaction with respect to the Products. Product names, descriptions, and labeling are of U.S. origin which may not be the user’s country of residence and that products may not be available in all countries.

Neither Pacira nor any of Pacira’s affiliates, nor any of their respective Agents undertakes any obligation to provide you or any other party with access to any additional information or to update or correct any inaccuracies in or omissions with respect to the Data, and the right is reserved, without giving reason, at any stage and in any respect to amend any content or proposed timetable, and to terminate any procedure or discussions or negotiations with you or any prospective purchaser.

In no circumstances will Pacira nor any of Pacira’s affiliates, nor any of their respective Agents be responsible for any costs or expenses incurred in connection with any appraisal or investigation of the Products or the viewing or use of the Data, or for any other costs and expenses incurred by you or any prospective purchasers in connection with any agreement or transaction related thereto.

The Data should not be considered as a recommendation by Pacira, nor any of Pacira’s affiliates, nor any of their respective Agents to enter into any agreement or transaction related to the Products or for the viewing or use of the Data. You are recommended to seek your own scientific, clinical, medical, financial and other advice as you, in your sole discretion, deem necessary and appropriate and should rely solely on your own judgment, review and analysis in evaluating the Data and Products.

IndicationThe iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue. The iovera° system’s “1x90” Smart Tip configuration (indicating one needle which is 90 mm long) can also facilitate target nerve location by conducting electrical nerve stimulation from a separate nerve stimulator.

Important Safety InformationThe iovera° system should not be used in people with the following conditions:

  • Blood that thickens when patient is exposed to cold (cryoglobulinemia), blood appearing in the urine when patient is exposed to the cold (paroxysmal cold hemoglobinuria), skin rash that appears when patient is exposed to the cold (cold urticaria), narrowing of the blood vessels in the hands and feet when patient is exposed to the cold (Raynaud’s disease), and open and/or infected wounds at or near the treatment site

Patients being treated with the iovera° system (a needle-based therapy) may experience certain reactions, including, but not limited to:

  • Bruising, swelling, inflammation and/or redness, local pain and/or tenderness, and altered feeling at the site of application

Proper use of the device as described in the User Guide can help reduce or prevent the following reactions:

  • In the area(s) where you were treated: damage to the skin from being exposed to cold or heat, darkening or lightening of the skin, and dimples in the skin
  • Outside the area(s) where you were treated: muscles may not work or move normally
SEE MORE

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain.

Important Safety Information